Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Share buy-back programme schedule from January to June 2024.pdf

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 48 / 2023
Date of issue: 2023-12-06
Short name of the issuer
KRKA
Subject
Share buy-back programme schedule from January to June 2024
Official market - legal basis
Unofficial market - legal basis
Contents of the report:
Based on the provisions of Article 26 of the Ljubljana Stock Exchange Rules, Article 158 of the Market in Financial Instruments Act, article 2 of the Commission Delegated regulation (EU) No 2016/2052 and Article 17 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto (hereinafter: Krka) discloses information regarding share buy-back programme (hereinafter: programme) schedule from January to June 2024.

Krka disclosed the start of the back programme on 20 July 2023 through the electronic dissemination system SEOnet.

The programme schedule for H1 2024 is attached.

The public will be regularly informed about these acquisitions of treasury shares.

This announcement will be published on the company’s website (www.krka.biz) starting from 6 December 2023, for a minimum period of 5 years.
Annexes
File Description
Share buy-back programme schedule from January to June 2024.pdf
Share buy-back programme schedule from January to June 2024.pdf

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-12-06 Jože Colarič President of the Management Board and CEO
20231206_101912_1581479224_Share_buy-back_programme_schedule_from_January_to_June_2024.pdf